Specifically, it was reported that five patients (14%) with lung ADC were found to have a diagnosis of SCLC in EGFR TKI-resistant tumor biopsies despite maintaining the original mutation and became sensitive to classical SCLC treatment (Sequist et al., 2011). Here, EGFR is linked to neoplasm.